Search clinical trials for: rabies vaccine

Total 10012 results

CSL Behring
CSL Plasma

Completed

Rabies Immune Plasma Booster Study

Rabies

United States
Jiangsu Province Centers for Disease Control and...

Completed

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

Rabies

China
Chulalongkorn University

Unknown

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Primary Immunodeficiency

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Increasing HAART-Induced Immune Restoration With Cyclosporine

HIV Infections

United States
Queen Saovabha Memorial Institute

Unknown

Observation Study an Immunogenicity Modified TRC-ID Regimen With CPRV With or Without Rabies Immunoglobulin in Children

Dog Bite
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

Japanese Encephalitis | Rabies

Austria, Germany, Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

Rabies

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Hepatitis C | Human Immunodeficiency Virus

United States, Puerto Rico
Leiden University Medical Center

Unknown

One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding

Rabies Pre-exposure Prophylaxis

Netherlands
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Rabies | Rabies Virus

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy Adults

Rabies

France
Novartis Vaccines

Completed

A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults

Rabies

China
Novartis Vaccines

Completed

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Rabies

India
Novartis
Novartis Vaccines

Completed

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Japanese Encephalitis | Rabies | Yellow Fever | Meningococcal Disease | Typhoid | Meningococcal Meningitis

Czech Republic, Germany
Queen Saovabha Memorial Institute

Completed

Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV

Efficacy of the New CPRV

Thailand
Centers for Disease Control and Prevention

Completed

Study of Intradermal Administration of PCEC Rabies Vaccine (Rabies-ID)

Rabies Prevention | Rabies Exposure

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Verorab™ in Indian Population

Rabies

India
University of Oxford
European and Developing Countries Clinical Trials Partnership (EDCTP)

Completed

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

Malaria

Senegal
University of Oxford
European and Developing Countries Clinical Trials Partnership (EDCTP)

Completed

Efficacy of Malaria Vaccines in Kenyan Adults

Malaria

Kenya
ConvaTec Inc.

Completed

Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers

Leg Ulcer

United Kingdom, Germany, Netherlands, Poland
Crucell Holland BV

Completed

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Rabies

India
Moses Murandu
University of Birmingham; Laboratoires URGO; University of Wolverhampton

Unknown

Use of White Granulated Sugar on Wounds

Infected Wounds

United Kingdom
Crucell Holland BV

Completed

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Rabies

Philippines
Novartis Vaccines

Terminated

Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen

Rabies

China
Novartis Vaccines

Completed

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

Rabies Post-exposure Prophylaxis

China
Novartis Vaccines

Completed

Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)

Rabies

China
U.S. Army Medical Research and Development Command
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

Phase I Pediatric FMP2.1/AS02A Trial in Mali

Plasmodium Falciparum Malaria

Mali
Crucell Holland BV

Completed

A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Rabies

United States
Peking University People's Hospital

Unknown

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Rabies

China
Provincial Public Health Office, Phetchabun

Completed

Early Rabies Vaccine Immunization in Primary School Children (I49P1)

Rabies Prevention

Thailand
African Malaria Network Trust

Unknown

Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years

Malaria

Gabon
Mahidol University
Chiron company: Clinical Research and Medical Affairs

Completed

Rabies Immunization Concomitant With JEV in Children

Rabies
Novartis
Novartis Vaccines

Completed

Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers

Japanese Encephalitis | Rabies | Pre-Exposure Prophylaxis

Thailand
Pfizer

Not yet recruiting

SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

Respiratory Tract Infection

Japan
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Not yet recruiting

Correlation of Protection Against Varicella in an Exploratory Study

Varicella
Johns Hopkins Bloomberg School of Public Health
Emory University; Children's Healthcare of Atlanta

Not yet recruiting

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

Vaccine Hesitancy | Vaccine Refusal

United States
Novavax

Not yet recruiting

Phase 3 Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

COVID-19
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Solid Tumor, Adult | DC

China
Pfizer

Not yet recruiting

A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults. (Amélie)

Respiratory Syncytial Virus (RSV)

United States
OSE Immunotherapeutics
Exystat; Genome Diagnostics (GenDx)

Not yet recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor (ARTEMIA)

Patients With Non-Small Cell Lung Cancer

United States
Sinovac Life Sciences Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of PCV24 in Adults

Pneumococcal Infectious Disease

China
University of Michigan
African Population and Health Research Center

Not yet recruiting

The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa

Vaccines

Kenya, Uganda
Shanghai Bovax Biotechnology Co., Ltd.

Not yet recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Anal Cancer | HPV-Related Carcinoma | Penile Cancer | Genital Wart | AIN3 | AIN2 | PIN-1 | AIN1 | PIN2 | PIN3

China
Genelux Corporation
Newsoara Biopharma Co., Ltd.

Not yet recruiting

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's of Choice Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (VIRO-25) ((VIRO-25))

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Advanced Non-squamous Non-small-cell Lung Cancer | Non-small Cell Lung Cancer Stage IV | Metastatic Squamous Non-Small Cell Lung Carcinoma | Non-small Cell Lung Cancer Recurrent | Metastatic Non-squamous Non Small Cell Lung Cancer and other conditions
InventVacc Biologicals Inc.
Hia Consortium

Recruiting

A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine

Haemophilus Influenzae Meningitis | Invasive Haemophilus Influenzae Disease

Canada
Laure Pittet, MD-PhD

Recruiting

Registry of Vaccine Responses in Immune Compromised Patients (REVAPI)

Immunosuppression

Switzerland
Sumitomo Pharma Co., Ltd.

Not yet recruiting

First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP

Influenza

Belgium
Massachusetts General Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh

Not yet recruiting

Correlates of Protection for Cholera (CoP)

Cholera
Shanghai Bovax Biotechnology Co., Ltd.

Not yet recruiting

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

HPV Infection | HPV-Related Carcinoma | Genital Wart | HPV-Related Intraepithelial Neoplasia

China
MAXVAX Biotechnology Limited Liability Company

Not yet recruiting

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Herpes Zoster

China

3

Subscribe